Yew Bio-Pharm Group, Inc.

YEWB · OTC
Analyze with AI
9/30/2021
6/30/2021
3/31/2021
12/31/2020
Assets
Cash & Equivalents$28$167$127$564
Short-Term Investments$0$0$0$0
Receivables$13,597$19,832$213$218
Inventory$123$110$14$15
Other Curr. Assets$0$0$15,403$9,193
Total Curr. Assets$13,934$20,520$15,757$9,989
Property Plant & Equip (Net)$827$834$824$823
Goodwill$0$0$0$0
Intangibles$45,737$40,829$41,424$41,980
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$900$1,070$3,925$5,654
Total NC Assets$47,463$42,734$46,172$48,457
Other Assets$0$0$0$0
Total Assets$61,397$63,254$61,929$58,447
Liabilities
Payables$1,117$1,982$1,208$424
Short-Term Debt$9,012$9,350$9,204$9,045
Tax Payable$1,088$0$0$974
Deferred Revenue$1,883$1,185$1,168$1
Other Curr. Liab.$532$980$758$1,055
Total Curr. Liab.$12,544$13,497$12,337$10,525
LT Debt$242$255$282$0
Deferred Rev, NC$0$0$0$1,173
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,812$1,185$1,168$1,266
Total NC Liab.$2,055$1,439$1,450$2,439
Other Liabilities$0$0$0$0
Cap. Leases$242$322$325$358
Total Liabilities$14,599$14,936$13,787$12,964
Equity
Pref Stock$0$0$0$0
Common Stock$52$52$52$52
Retained Earnings$32,239$33,789$34,334$31,416
AOCI$1,118$1,079$356$4,371
Other Equity$13,407$13,407$13,407$14,015
Total Equity$46,816$48,327$48,149$45,483
Supplemental Information
Minority Interest-$18-$9-$6$0
Total Liab. & Tot. Equity$61,397$63,254$61,929$58,447
Net Debt$9,226$9,437$9,359$8,482